Q2 2023 · 13F-HR
Opaleye Management Inc.holdings as filed
Filed 2023-08-14 · accession 0001493152-23-028636
$418.1M
Reported value
47
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 00445A100 | — | ACELYRIN INC | $86.9M | 20.8% | 4,158,638 | Common | SOLE |
| 415858109 | HROW | HARROW HEALTH INC | $71.9M | 17.2% | 3,775,000 | Common | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $29.8M | 7.13% | 5,780,000 | Common | SOLE |
| 872381108 | TELA | TELA BIO INC | $16.0M | 3.83% | 1,580,000 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS INC | $15.2M | 3.64% | 845,000 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $14.2M | 3.39% | 352,650 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $12.9M | 3.09% | 540,000 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $12.1M | 2.90% | 735,000 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $9.8M | 2.33% | 415,000 | Common | SOLE |
| 617760202 | MOR2 | MORPHOSYS AG | $9.0M | 2.16% | 1,209,380 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $8.8M | 2.11% | 177,000 | Common | SOLE |
| 29772L108 | ETON | ETON PHARMACEUTICALS INC | $8.0M | 1.91% | 2,285,000 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $7.5M | 1.80% | 2,350,000 | Common | SOLE |
| 56854Q200 | MRNS* | MARINUS PHARMACEUTICALS INC | $6.8M | 1.62% | 625,000 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $6.5M | 1.55% | 720,000 | Common | SOLE |
| 74365U107 | TARA | PROTARA THERAPEUTICS INC | $6.4M | 1.54% | 2,692,594 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $6.3M | 1.51% | 815,000 | Common | SOLE |
| 23257D103 | CBAYUSD | CYMABAY THERAPEUTICS INC | $6.2M | 1.48% | 566,700 | Common | SOLE |
| M96088105 | URGN | UROGEN PHARMA LTD | $5.9M | 1.41% | 570,000 | Common | SOLE |
| G8807B106 | TBPH | THERAVANCE BIOPHARMA INC | $5.6M | 1.35% | 543,500 | Common | SOLE |
| 88369M101 | — | THESEUS PHARMACEUTICALS INC | $5.6M | 1.33% | 597,500 | Common | SOLE |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $5.2M | 1.24% | 217,000 | Common | SOLE |
| 45826J105 | NTLA | INTELLIA THERAPEUTICS INC | $4.9M | 1.17% | 120,000 | Common | SOLE |
| 53635D202 | LQDA | LIQUIDIA CORPORATION | $4.5M | 1.07% | 570,700 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $4.4M | 1.04% | 1,390,000 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $4.2M | 1.01% | 130,000 | Common | SOLE |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $4.1M | 0.97% | 1,701,500 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $4.0M | 0.97% | 3,370,000 | Common | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS INC | $4.0M | 0.96% | 221,700 | Common | SOLE |
| B6S7WD106 | NYXH | NYXOAH S A | $3.6M | 0.85% | 445,000 | Common | SOLE |
| 268311107 | EDAP | EDAP TMS S A | $3.5M | 0.84% | 380,000 | Common | SOLE |
| 48576U106 | KPTIEUR | KARYOPHARM THERAPEUTICS INC | $3.2M | 0.76% | 1,785,000 | Common | SOLE |
| 462260100 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $3.0M | 0.71% | 421,000 | Common | SOLE |
| 85916J409 | STXS | SPECTRUM PHARMACEUTICALS | $3.0M | 0.71% | 3,074,995 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $2.5M | 0.61% | 305,000 | Common | SOLE |
| 192005106 | CDXS | CODEXIS INC | $1.9M | 0.45% | 675,000 | Common | SOLE |
| 34960Q109 | — | FORTRESS BIOTECH INC | $1.8M | 0.44% | 3,310,000 | Common | SOLE |
| 869367102 | — | SUTRO BIOPHARMA INC | $1.4M | 0.34% | 307,000 | Common | SOLE |
| 09203E105 | BDTX | BLACK DIAMOND THERAPEUTICS | $1.4M | 0.33% | 275,000 | Common | SOLE |
| 89237H209 | — | TRACON PHARMACEUTICALS INC | $1.4M | 0.33% | 4,764,508 | Common | SOLE |
| N71542109 | PRQR | PROQR THERAPEUTICS NV | $1.1M | 0.25% | 653,000 | Common | SOLE |
| 481116101 | — | JASPER | $917,823 | 0.22% | 669,944 | Common | SOLE |
| 92337C203 | VSTM | VERASTEM INC | $758,880 | 0.18% | 102,000 | Common | SOLE |
| 98419J206 | XOMA | XOMA CORP DEL | $594,750 | 0.14% | 275,000 | Common | SOLE |
| 449585108 | 1K0 | IGM BIOSCIIENCES INC | $586,105 | 0.14% | 63,500 | Common | SOLE |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $473,880 | 0.11% | 143,600 | Common | SOLE |
| 49372L100 | — | KEZAR LIFE SCIENCES INC | $242,050 | 0.06% | 98,796 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.